EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma

被引:202
|
作者
Oosterlinck, W
Solsona, E
van der Meijden, APM
Sylvester, R
Böhle, A
Rintala, E
Lobel, B
机构
[1] Ghent Univ Hosp, Dept Urol, B-9000 Ghent, Belgium
[2] Inst Valenciano Oncol, Dept Urol, Valencia, Spain
[3] Jeroen Bosch Hosp, Dept Urol, sHertogenbosch, Netherlands
[4] Eortc Data Ctr, Brussels, Belgium
[5] Helios Agnes Karll Hosp, Dept Urol, Bad Schwartau, Germany
[6] Univ Helsinki Hosp, Dept Urol, Helsinki, Finland
[7] Hop Pontchaillou, Dept Urol, Rennes, France
关键词
transitional cell carcinoma of the upper urinary tract; bladder cancer; guidelines;
D O I
10.1016/j.eururo.2004.04.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of upper urinary tract transitional cell carcinoma (UUTT) patients were established. Criteria for recommendations are based of level 2 only, as large randomised clinical trials have not been performed in this type of disease. Method: A systematic literature research using Medline Services was conducted. References were weighted by a panel of experts. Results: TNM classification 2002 is recommended. Recommendations are developed for diagnosis, radical and conservative treatment and for local chemo-immunotherapy. Prognostic factors are defined. Recommendations for follow-up after different types of treatment are given. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 50 条
  • [41] Hand-assisted laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract
    Stifelman, MD
    Sosa, RE
    Andrade, A
    Tarantino, A
    Shichman, SJ
    UROLOGY, 2000, 56 (05) : 741 - 747
  • [42] Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?
    Brown, Gordon A.
    Busby, J. Erik
    Wood, Christopher G.
    Pisters, Louis L.
    Dinney, Colin P. N.
    Swanson, David A.
    Grossman, H. Barton
    Pettaway, Curtis A.
    Munsell, Mark F.
    Kamat, Ashish M.
    Matin, Surena F.
    BJU INTERNATIONAL, 2006, 98 (06) : 1176 - 1180
  • [43] Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract
    Kwak, Cheol
    Lee, Sang Eun
    Jeong, In Gab
    Ku, Ja Hyeon
    UROLOGY, 2006, 68 (01) : 53 - 57
  • [45] UPDATE ON ORGAN-SPARING TREATMENT OF UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA (UUTTCC)
    Malm, C.
    Brehmer, M.
    JOURNAL OF ENDOUROLOGY, 2010, 24 : A321 - A321
  • [46] Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches
    Argyropoulos, Athanasios N.
    Tolley, David A.
    BJU INTERNATIONAL, 2007, 99 (05) : 982 - 987
  • [47] TREATMENT OPTIONS FOR UPPER TRACT TRANSITIONAL-CELL CARCINOMA
    SEAMAN, EK
    SLAWIN, KM
    BENSON, MC
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (02) : 349 - 354
  • [48] CYTOLOGICAL DIAGNOSIS OF TRANSITIONAL CELL-CARCINOMA OF URINARY-TRACT
    FELDMAN, M
    CANADIAN JOURNAL OF MEDICAL TECHNOLOGY, 1974, 36 (04): : 285 - &
  • [49] Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract
    Koga, F
    Nagamatsu, H
    Ishimaru, H
    Mizuo, T
    Yoshida, K
    UROLOGIA INTERNATIONALIS, 2001, 67 (02) : 135 - 141
  • [50] Independent predictors of metachronous bladder transitional cell carcinoma after nephroureterectomy for transitional cell carcinoma of the upper urinary tract
    Novara, G.
    De Marco, V.
    Dalpiaz, O.
    Bouygues, V.
    Galfano, A.
    Martignoni, G.
    Patand, J. J.
    Artibani, W.
    Ficarra, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 136 - 136